Recently, a study based on data from one patient cohort reported that USP33 expression was found to be reduced in GC and that reduced USP33 expression was associated with poor prognosis.23 However, the precise molecular mechanisms of how USP33 exerts the anti‐tumour function in GC remain to be elucidated. The gene discussed is USP33; the disease is gastric cancer.